[THE EXCRETION OF ADRENAL CORTEX STEROIDS IN PATIENTS WITH HIRSUTISM AFTER ORAL ADMINISTRATION OF METOPIRON].
D015068:17-Ketosteroids; D000284:Administration, Oral; D000302:Adrenal Cortex; D000305:Adrenal Cortex Hormones; D000738:Androsterone; D005043:Etiocholanolone; D005260:Female; D006628:Hirsutism; D006801:Humans; D006983:Hypertrichosis; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D011085:Polycystic Ovary Syndrome; D014556:Urine
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D000451:Mineralocorticoid Receptor Antagonists; D005043:Etiocholanolone; D000738:Androsterone; D008797:Metyrapone
17-KETOSTEROIDS; ADRENAL CORTEX HORMONES; ALDOSTERONE ANTAGONISTS; ANDROSTERONE; ETIOCHOLANOLONE; HYPERTRICHOSIS; METYRAPONE; STEIN-LEVENTHAL SYNDROME; URINE
DIE AUSSCHEIDUNG VON NNR-STEROIDEN BEI PATIENTEN MIT HIRUTISMUS NACH PEROR.ER VERABREICHUNG VON METOPIRON.